These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 11895493)
61. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244 [TBL] [Abstract][Full Text] [Related]
62. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823 [TBL] [Abstract][Full Text] [Related]
63. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre. Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345 [TBL] [Abstract][Full Text] [Related]
64. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N World J Surg; 2008 Dec; 32(12):2675-80. PubMed ID: 18843437 [TBL] [Abstract][Full Text] [Related]